{"entity":{"type":"insider","cik":"0001283303","url":"/insider/0001283303","json_url":"/insider/0001283303.json","name":"REED ELIZABETH E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":77,"n_filings":45,"first":"2006-01-11","last":"2026-05-06","span_basis":"filed_date"},"name_variants":[{"name":"REED ELIZABETH E","source":"filing","n_filings":45,"first_seen":"2006-01-11","last_seen":"2026-05-06"}],"transactions":[{"id":5931578,"accession":"0001283303-26-000009","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001283303-26-000009","line_url":"/filing/0001283303-26-000009#line-5","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2076.0,"shares_display":"2,076","price_per_share":43.95,"price_display":"43.95","price_state":"stated","total_value":91240.2,"total_display":"91,240.20","total_whole":"91,240","shares_owned_after":105211.0,"shares_owned_after_display":"105,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-06","filed_date":"2026-05-06","scope":"insider"},{"id":5931576,"accession":"0001283303-26-000009","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001283303-26-000009","line_url":"/filing/0001283303-26-000009#line-4","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2174.0,"shares_display":"2,174","price_per_share":46.65,"price_display":"46.65","price_state":"stated","total_value":101417.1,"total_display":"101,417.10","total_whole":"101,417","shares_owned_after":107287.0,"shares_owned_after_display":"107,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-06","scope":"insider"},{"id":5931573,"accession":"0001283303-26-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001283303-26-000009","line_url":"/filing/0001283303-26-000009#line-3","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","total_whole":"900,000","shares_owned_after":105211.0,"shares_owned_after_display":"105,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-06","scope":"insider"},{"id":6007985,"accession":"0001283303-26-000008","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001283303-26-000008","line_url":"/filing/0001283303-26-000008","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6785.0,"shares_display":"6,785","price_per_share":41.82909211495947,"price_display":"41.83","price_state":"stated","total_value":283810.39,"total_display":"283,810.39","total_whole":"283,810","shares_owned_after":106770.0,"shares_owned_after_display":"106,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-15","scope":"insider","n_lines":2},{"id":6007979,"accession":"0001283303-26-000008","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001283303-26-000008","line_url":"/filing/0001283303-26-000008","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44715.0,"shares_display":"44,715","price_per_share":41.20857188862798,"price_display":"41.21","price_state":"stated","total_value":1842641.292,"total_display":"1,842,641.29","total_whole":"1,842,641","shares_owned_after":119211.0,"shares_owned_after_display":"119,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-14","filed_date":"2026-04-15","scope":"insider","n_lines":2},{"id":6090955,"accession":"0001283303-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001283303-26-000007","line_url":"/filing/0001283303-26-000007#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":105211.0,"shares_owned_after_display":"105,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider"},{"id":5750788,"accession":"0001283303-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001283303-26-000006","line_url":"/filing/0001283303-26-000006#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.0861,"price_display":"28.09","price_state":"stated","total_value":280861.0,"total_display":"280,861.00","total_whole":"280,861","shares_owned_after":105211.0,"shares_owned_after_display":"105,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-18","scope":"insider"},{"id":5945710,"accession":"0001283303-26-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001283303-26-000005","line_url":"/filing/0001283303-26-000005","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":27.8315318,"price_display":"27.83","price_state":"stated","total_value":278315.318,"total_display":"278,315.32","total_whole":"278,315","shares_owned_after":109532.0,"shares_owned_after_display":"109,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider","n_lines":2},{"id":5897967,"accession":"0001283303-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001283303-26-000003","line_url":"/filing/0001283303-26-000003","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2994.0,"shares_display":"2,994","price_per_share":32.1839044756179,"price_display":"32.18","price_state":"stated","total_value":96358.61,"total_display":"96,358.61","total_whole":"96,359","shares_owned_after":105720.0,"shares_owned_after_display":"105,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-05","scope":"insider","n_lines":2},{"id":5931567,"accession":"0001283303-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001283303-26-000002","line_url":"/filing/0001283303-26-000002#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7175.0,"shares_display":"7,175","price_per_share":32.12,"price_display":"32.12","price_state":"stated","total_value":230461.0,"total_display":"230,461.00","total_whole":"230,461","shares_owned_after":108205.0,"shares_owned_after_display":"108,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-03","scope":"insider"},{"id":5985559,"accession":"0001283303-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001283303-26-000001","line_url":"/filing/0001283303-26-000001#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":27.342,"price_display":"27.34","price_state":"stated","total_value":273420.0,"total_display":"273,420.00","total_whole":"273,420","shares_owned_after":90270.0,"shares_owned_after_display":"90,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":5072711,"accession":"0001283303-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001283303-25-000005","line_url":"/filing/0001283303-25-000005#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":89878.0,"shares_owned_after_display":"89,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-22","filed_date":"2025-09-24","scope":"insider"},{"id":4641118,"accession":"0001415889-25-012054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-012054","line_url":"/filing/0001415889-25-012054#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4920.0,"shares_display":"4,920","price_per_share":21.05,"price_display":"21.05","price_state":"stated","total_value":103566.0,"total_display":"103,566.00","total_whole":"103,566","shares_owned_after":89482.0,"shares_owned_after_display":"89,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-05","filed_date":"2025-05-05","scope":"insider"},{"id":4860389,"accession":"0001415889-25-003823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-003823","line_url":"/filing/0001415889-25-003823#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark":"O","role_mark_label":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & CORPORATE SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":23.53,"price_display":"23.53","price_state":"stated","total_value":188240.0,"total_display":"188,240.00","total_whole":"188,240","shares_owned_after":89482.0,"shares_owned_after_display":"89,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-12","scope":"insider"},{"id":4885124,"accession":"0001415889-25-003066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-003066","line_url":"/filing/0001415889-25-003066#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark":"O","role_mark_label":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & CORPORATE SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8951.0,"shares_display":"8,951","price_per_share":19.78,"price_display":"19.78","price_state":"stated","total_value":177050.78,"total_display":"177,050.78","total_whole":"177,051","shares_owned_after":89482.0,"shares_owned_after_display":"89,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":4210271,"accession":"0001415889-25-002004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-002004","line_url":"/filing/0001415889-25-002004#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark":"O","role_mark_label":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & CORPORATE SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2437.0,"shares_display":"2,437","price_per_share":19.46,"price_display":"19.46","price_state":"stated","total_value":47424.02,"total_display":"47,424.02","total_whole":"47,424","shares_owned_after":76933.0,"shares_owned_after_display":"76,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":2863742,"accession":"0001415889-24-023095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023095","line_url":"/filing/0001415889-24-023095#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark":"O","role_mark_label":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & CORPORATE SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4387.0,"shares_display":"4,387","price_per_share":11.52,"price_display":"11.52","price_state":"stated","total_value":50538.24,"total_display":"50,538.24","total_whole":"50,538","shares_owned_after":78633.0,"shares_owned_after_display":"78,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-09","scope":"insider"},{"id":2743209,"accession":"0001415889-24-002283","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-002283","line_url":"/filing/0001415889-24-002283","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark":"O","role_mark_label":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & CORPORATE SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4764.0,"shares_display":"4,764","price_per_share":8.710183837111671,"price_display":"8.71","price_state":"stated","total_value":41495.3158,"total_display":"41,495.32","total_whole":"41,495","shares_owned_after":76270.0,"shares_owned_after_display":"76,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-02","scope":"insider","n_lines":2},{"id":2273160,"accession":"0001415889-24-001801","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-001801","line_url":"/filing/0001415889-24-001801#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark":"O","role_mark_label":"Officer (SVP, GC & CORPORATE SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & CORPORATE SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2062.0,"shares_display":"2,062","price_per_share":8.96,"price_display":"8.96","price_state":"stated","total_value":18475.52,"total_display":"18,475.52","total_whole":"18,476","shares_owned_after":56034.0,"shares_owned_after_display":"56,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-25","scope":"insider"},{"id":7816399,"accession":"0001209191-23-048256","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-048256","line_url":"/filing/0001209191-23-048256#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1815.0,"shares_display":"1,815","price_per_share":14.71,"price_display":"14.71","price_state":"stated","total_value":26698.65,"total_display":"26,698.65","total_whole":"26,699","shares_owned_after":58096.0,"shares_owned_after_display":"58,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-05","scope":"insider"},{"id":8579816,"accession":"0001209191-23-029012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-029012","line_url":"/filing/0001209191-23-029012#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":825.0,"shares_display":"825","price_per_share":16.59,"price_display":"16.59","price_state":"stated","total_value":13686.75,"total_display":"13,686.75","total_whole":"13,687","shares_owned_after":56611.0,"shares_owned_after_display":"56,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-12","scope":"insider"},{"id":7967026,"accession":"0001209191-23-006436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-006436","line_url":"/filing/0001209191-23-006436#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2590.0,"shares_display":"2,590","price_per_share":22.25,"price_display":"22.25","price_state":"stated","total_value":57627.5,"total_display":"57,627.50","total_whole":"57,628","shares_owned_after":57436.0,"shares_owned_after_display":"57,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-02","scope":"insider"},{"id":8743151,"accession":"0001209191-23-005035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005035","line_url":"/filing/0001209191-23-005035#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2062.0,"shares_display":"2,062","price_per_share":21.5,"price_display":"21.50","price_state":"stated","total_value":44333.0,"total_display":"44,333.00","total_whole":"44,333","shares_owned_after":39776.0,"shares_owned_after_display":"39,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-26","scope":"insider"},{"id":6125288,"accession":"0001209191-22-028708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-028708","line_url":"/filing/0001209191-22-028708#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1050.0,"shares_display":"1,050","price_per_share":21.509,"price_display":"21.51","price_state":"stated","total_value":22584.45,"total_display":"22,584.45","total_whole":"22,584","shares_owned_after":41838.0,"shares_owned_after_display":"41,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-12","scope":"insider"},{"id":6125283,"accession":"0001209191-22-028708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-028708","line_url":"/filing/0001209191-22-028708#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":21.51,"price_display":"21.51","price_state":"stated","total_value":19359.0,"total_display":"19,359.00","total_whole":"19,359","shares_owned_after":42888.0,"shares_owned_after_display":"42,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-12","scope":"insider"},{"id":6776944,"accession":"0001209191-22-006369","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-006369","line_url":"/filing/0001209191-22-006369#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1350.0,"shares_display":"1,350","price_per_share":27.4,"price_display":"27.40","price_state":"stated","total_value":36990.0,"total_display":"36,990.00","total_whole":"36,990","shares_owned_after":43788.0,"shares_owned_after_display":"43,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-02-02","scope":"insider"},{"id":6242515,"accession":"0001209191-22-005081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-005081","line_url":"/filing/0001209191-22-005081#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":24.98,"price_display":"24.98","price_state":"stated","total_value":56205.0,"total_display":"56,205.00","total_whole":"56,205","shares_owned_after":35298.0,"shares_owned_after_display":"35,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-26","scope":"insider"},{"id":6119863,"accession":"0001209191-22-003053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-003053","line_url":"/filing/0001209191-22-003053#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":27.4,"price_display":"27.40","price_state":"stated","total_value":137000.0,"total_display":"137,000.00","total_whole":"137,000","shares_owned_after":37548.0,"shares_owned_after_display":"37,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-12","scope":"insider"},{"id":4103463,"accession":"0001209191-21-052078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-052078","line_url":"/filing/0001209191-21-052078#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1407.0,"shares_display":"1,407","price_per_share":17.1187,"price_display":"17.12","price_state":"stated","total_value":24086.0109,"total_display":"24,086.01","total_whole":"24,086","shares_owned_after":37548.0,"shares_owned_after_display":"37,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-17","scope":"insider"},{"id":4892617,"accession":"0001209191-21-032316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-032316","line_url":"/filing/0001209191-21-032316#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":19.46,"price_display":"19.46","price_state":"stated","total_value":31622.5,"total_display":"31,622.50","total_whole":"31,623","shares_owned_after":34455.0,"shares_owned_after_display":"34,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":4892611,"accession":"0001209191-21-032316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-032316","line_url":"/filing/0001209191-21-032316#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":19.14,"price_display":"19.14","price_state":"stated","total_value":31102.5,"total_display":"31,102.50","total_whole":"31,103","shares_owned_after":36080.0,"shares_owned_after_display":"36,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":4415539,"accession":"0001209191-21-008804","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-008804","line_url":"/filing/0001209191-21-008804#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":31.58,"price_display":"31.58","price_state":"stated","total_value":71055.0,"total_display":"71,055.00","total_whole":"71,055","shares_owned_after":37705.0,"shares_owned_after_display":"37,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider"},{"id":4415531,"accession":"0001209191-21-008804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-008804","line_url":"/filing/0001209191-21-008804#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":31.41,"price_display":"31.41","price_state":"stated","total_value":70672.5,"total_display":"70,672.50","total_whole":"70,673","shares_owned_after":39955.0,"shares_owned_after_display":"39,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"},{"id":5035094,"accession":"0001209191-21-007633","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-007633","line_url":"/filing/0001209191-21-007633","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3175.0,"shares_display":"3,175","price_per_share":28.91,"price_display":"28.91","price_state":"stated","total_value":91789.25,"total_display":"91,789.25","total_whole":"91,789","shares_owned_after":38380.0,"shares_owned_after_display":"38,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-03","scope":"insider","n_lines":2},{"id":5422406,"accession":"0001209191-21-007026","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-007026","line_url":"/filing/0001209191-21-007026","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3175.0,"shares_display":"3,175","price_per_share":30.75,"price_display":"30.75","price_state":"stated","total_value":97631.25,"total_display":"97,631.25","total_whole":"97,631","shares_owned_after":41555.0,"shares_owned_after_display":"41,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-02","scope":"insider","n_lines":2},{"id":5422108,"accession":"0001209191-21-002595","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-002595","line_url":"/filing/0001209191-21-002595#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":688.0,"shares_display":"688","price_per_share":27.01,"price_display":"27.01","price_state":"stated","total_value":18582.88,"total_display":"18,582.88","total_whole":"18,583","shares_owned_after":24055.0,"shares_owned_after_display":"24,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-07","scope":"insider"},{"id":5422105,"accession":"0001209191-21-002595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-002595","line_url":"/filing/0001209191-21-002595#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":688.0,"shares_display":"688","price_per_share":26.65,"price_display":"26.65","price_state":"stated","total_value":18335.2,"total_display":"18,335.20","total_whole":"18,335","shares_owned_after":24743.0,"shares_owned_after_display":"24,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-07","scope":"insider"},{"id":2884009,"accession":"0001209191-20-058944","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058944","line_url":"/filing/0001209191-20-058944#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":23.98,"price_display":"23.98","price_state":"stated","total_value":59950.0,"total_display":"59,950.00","total_whole":"59,950","shares_owned_after":25431.0,"shares_owned_after_display":"25,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-17","scope":"insider"},{"id":3285111,"accession":"0001209191-20-058419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-058419","line_url":"/filing/0001209191-20-058419#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":23.6182,"price_display":"23.62","price_state":"stated","total_value":59045.5,"total_display":"59,045.50","total_whole":"59,046","shares_owned_after":27931.0,"shares_owned_after_display":"27,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-13","scope":"insider"},{"id":2512698,"accession":"0001209191-20-051735","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-051735","line_url":"/filing/0001209191-20-051735#line-1","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":18.48,"price_display":"18.48","price_state":"stated","total_value":27720.0,"total_display":"27,720.00","total_whole":"27,720","shares_owned_after":25431.0,"shares_owned_after_display":"25,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-23","scope":"insider"},{"id":2689454,"accession":"0001209191-20-051613","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-051613","line_url":"/filing/0001209191-20-051613#line-2","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":18.59,"price_display":"18.59","price_state":"stated","total_value":27885.0,"total_display":"27,885.00","total_whole":"27,885","shares_owned_after":26931.0,"shares_owned_after_display":"26,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-22","filed_date":"2020-09-22","scope":"insider"},{"id":2682287,"accession":"0001209191-20-029024","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-029024","line_url":"/filing/0001209191-20-029024","is_derivative":false,"issuer_cik":"0001283303","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001283303","owner_cik":"0001283303","owner_name":"REED ELIZABETH E","owner_display_name":"REED ELIZABETH E","owner_url":"/insider/0001283303","role":"Officer (SVP, GC & Corporate Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Corporate Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Corporate Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1052.0,"shares_display":"1,052","price_per_share":17.071982984790875,"price_display":"17.07","price_state":"stated","total_value":17959.7261,"total_display":"17,959.73","total_whole":"17,960","shares_owned_after":25431.0,"shares_owned_after_display":"25,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-13","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2020-05-12|2682282","ledger_fault":false,"count":{"value":77,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":77,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":77},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001438533","name":"Travere Therapeutics, Inc.","url":"/issuer/0001438533","role":"Officer (Chief Legal Officer and GC)","n_filings":42,"first_seen":"2018-01-08","last_seen":"2026-05-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001128495","name":"ANADYS PHARMACEUTICALS INC","url":"/issuer/0001128495","role":"Officer (Senior Director, Legal Affairs)","n_filings":3,"first_seen":"2006-01-11","last_seen":"2006-04-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001283303","retrieved_at":"2026-08-27T02:11:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}